Literature DB >> 27234486

Prediction for Improvement of Liver Function after Balloon-Occluded Retrograde Transvenous Obliteration for Gastric Varices to Manage Portosystemic Shunt Syndrome.

Akira Yamamoto1, Norifumi Nishida2, Hiroyasu Morikawa3, Atsushi Jogo1, Ken Kageyama1, Etsuji Sohgawa1, Shinichi Hamamoto1, Toru Takeshita1, Yukimasa Sakai1, Toshiyuki Matsuoka1, Norifumi Kawada4, Yukio Miki1.   

Abstract

PURPOSE: To investigate predictive factors and cutoff value of transient elastography (TE) measurements for assessing improvement in liver function after balloon-occluded retrograde transvenous obliteration (BRTO) for gastric varices (GV).
MATERIALS AND METHODS: Retrospective analysis was performed of 50 consecutive patients followed for > 3 months after BRTO, who had undergone TE before BRTO between January 2011 and February 2015. The correlation between change in liver function (total bilirubin, albumin, and prothrombin time) and baseline liver function values and liver stiffness measurement (LSM) by TE was evaluated by Pearson correlation test. Receiver operating characteristic curves were used to determine cutoff values for discriminating between patients who had improved liver function and patients who did not. The time interval from BRTO to aggravation of esophageal varices (EV) (worsening morphology, development of new varices, or variceal rupture) grouped by cutoff values was also analyzed.
RESULTS: Serum albumin was significantly improved at 3 months after BRTO (3.57 g/dL vs 3.74 g/dL, P < .001). There was a significant negative correlation between change in albumin and baseline LSM (r = -0.50, P < .001). The best cutoff point for LSM was ≤ 22.9 kPa, with sensitivity and specificity of 78.4% and 69.2%, respectively, for predicting which patients would have improved albumin after BRTO. Among 33 patients, 29 (88%) patients had improved albumin. The 1-year progression rate of EV after BRTO was 13.6% in patients with LSM ≤ 22.9 kPa.
CONCLUSIONS: The predictive factor for improvement in albumin after BRTO was lower LSM (≤ 22.9 kPa) using TE.
Copyright © 2016 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27234486     DOI: 10.1016/j.jvir.2016.03.031

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  6 in total

Review 1.  Evolution of Retrograde Transvenous Obliteration Techniques.

Authors:  Mihir Patel; Christopher Molvar
Journal:  Semin Intervent Radiol       Date:  2018-08-06       Impact factor: 1.513

2.  Role of endoscopic treatment or balloon-occluded retrograde transvenous obliteration in patients with Child-Pugh class C end-stage liver cirrhosis and esophageal/gastric varices.

Authors:  Jin Wook Chung
Journal:  Clin Mol Hepatol       Date:  2018-12-21

3.  Utility of Coil-Assisted Retrograde Transvenous Obliteration II (CARTO-II) for the Treatment of Gastric Varices.

Authors:  Akira Yamamoto; Atsushi Jogo; Ken Kageyama; Etsuji Sohgawa; Shinichi Hamamoto; Masao Hamuro; Toshio Kamino; Yukio Miki
Journal:  Cardiovasc Intervent Radiol       Date:  2019-12-24       Impact factor: 2.740

4.  Endoscopic injection sclerotherapy improves liver function compared with endoscopic variceal ligation.

Authors:  Tsuguru Hayashi; Tatsuyuki Watanabe; Michihiko Shibata; Shinsuke Kumei; Shinji Oe; Koichiro Miyagawa; Yuichi Honma; Masaru Harada
Journal:  Sci Rep       Date:  2021-10-14       Impact factor: 4.379

5.  Spontaneous portosystemic shunt diameter predicts liver function after balloon-occluded retrograde transvenous obliteration.

Authors:  Akihisa Tatsumi; Shinya Maekawa; Leona Osawa; Ryo Katoh; Yasuyuki Komiyama; Natsuko Nakakuki; Hitomi Takada; Shuya Matsuda; Masaru Muraoka; Yuichiro Suzuki; Mitsuaki Sato; Ei Takahashi; Mika Miura; Fumitake Amemiya; Shinichi Takano; Mitsuharu Fukasawa; Tatsuya Yamaguchi; Yasuhiro Nakayama; Taisuke Inoue; Hiroki Okada; Takuji Araki; Hiroshi Onishi; Nobuyuki Enomoto
Journal:  JGH Open       Date:  2022-01-28

6.  Improved Hepatic Reserve and Fibrosis in a Case of "Portal-Systemic Liver Failure" by Portosystemic Shunt Occlusion.

Authors:  Tsuyoshi Ishikawa; Ryo Sasaki; Tatsuro Nishimura; Takuya Iwamoto; Taro Takami; Takahiro Yamasaki; Isao Sakaida
Journal:  Am J Case Rep       Date:  2020-02-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.